Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessment of split renal function with 99mTc-aprotinin.

C Aprile, R Saponaro, G Villa

    European Journal of Nuclear Medicine
    |January 1, 1986
    PubMed
    Summary

    99mTc-aprotinin (TcA) kidney uptake accurately reflects kidney function, correlating significantly with effective renal plasma flow (ERPF) and blood chemistry. TcA is a feasible indicator of split renal function, even at 90 minutes postinjection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.

    Hematological oncology·2024
    Same author

    Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study.

    European journal of haematology·2024
    Same author

    Systematic review of clinical evidence on postoperative delirium: literature search of original studies based on validated diagnostic scales.

    Journal of anesthesia, analgesia and critical care·2023
    Same author

    Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.

    Frontiers in pharmacology·2023
    Same author

    HIV and chronic hepatitis B virus co-infection in sub-Saharan Africa: a deadly synergy.

    Public health action·2020
    Same author

    Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes.

    Pharmacological research·2020

    Area of Science:

    • Nuclear medicine
    • Renal imaging
    • Radiopharmaceuticals

    Background:

    • Assessing split renal function is crucial for diagnosing and managing kidney diseases.
    • Effective renal plasma flow (ERPF) and blood chemistry parameters are key indicators of kidney function.
    • 99mTc-aprotinin (TcA) is a radiopharmaceutical used in kidney imaging.

    Purpose of the Study:

    • To correlate net kidney uptake of 99mTc-aprotinin (TcA) with separate effective renal plasma flow (ERPF) and blood chemistry parameters.
    • To evaluate TcA as an indicator of split renal function at different time points postinjection (90, 180, and 360 min).
    • To compare TcA with DMSA for renal uptake measurements in diseased kidneys.

    Main Methods:

    • Correlational analysis between TcA kidney uptake and ERPF in 103 subjects.

    Related Experiment Videos

  • Analysis of blood chemistry parameters (urea, creatinine, clearances) in relation to TcA uptake.
  • Comparison of TcA and DMSA uptake in 20 additional patients with diseased kidneys.

    • Main Results:

    • Highly significant correlations (P < 0.001) were found between TcA uptake and ERPF at all time points.
    • TcA uptake showed significant correlations with urea, creatinine, urea clearance, and creatinine clearance.
    • TcA demonstrated better correlations with ERPF compared to DMSA in diseased kidneys at 360 min.
    • Early scans (90 min) better reflect renal blood flow, while later scans relate to tubular function.

    Conclusions:

    • 99mTc-aprotinin (TcA) is a feasible and reliable indicator of split renal function.
    • TcA imaging at 90 minutes postinjection provides valuable information for outpatient kidney assessment.
    • TcA offers a valuable tool for evaluating renal plasma flow and kidney function.